SLAB51 to spare oxygen during infections from respiratory syncytial virus, COVID-19 and influenza

By Professor Claudio De Simone 
From Medical Xpress

Newspaper headlines from the U.S. to the U.K. and most places in between highlight the surge in sick patients suffering from respiratory viruses. The so-called “tripledemic” of lung infections including respiratory synclinal virus (RSV), influenza (flu) and COVID-19 (coronavirus) is likely to last throughout the winter season. This explosion of infections requires more treatment options to support overloaded hospitals and overworked medics as they restore people’s health.

The human intestine receives almost one-third of the body’s cardiac output. What if we could spare oxygen in the gut and redistribute oxygen to other body districts to avoid intubation of certain vulnerable patient groups?

The administration of SLAB51 offers a complementary approach to standard care for treating the hypoxia observed during not just COVID-19 infections but other respiratory viruses such as respiratory syncytial virus (RSV) and the flu.

Pr De Simone, About

Share this article!

Categories: Covid, Slab51